Drug Type Small molecule drug |
Synonyms 太罗 |
Target |
Mechanism PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists), Insulin sensitizers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (14 Sep 2004), |
Regulation- |
Molecular FormulaC18H19N3NaO3S |
InChIKeyMIXMIJXAFUYUNO-UHFFFAOYSA-N |
CAS Registry316371-83-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | CN | 14 Sep 2004 |
Phase 3 | 149 | Rosiglitazone (Rosiglitazone 4 mg Orally Once Daily) | eelhabfnhc(djannpdvzh) = zdvxjwtmug hmnwhiueow (xuannmelfd, oyipsbnksr - riyzmevrxc) View more | - | 08 Feb 2019 | ||
sulphonylureas+glibenclamide+glimepiride+gliclazide (Placebo) | eelhabfnhc(djannpdvzh) = rskoptpbls hmnwhiueow (xuannmelfd, fpbveisdia - torxlfodcj) View more | ||||||
Not Applicable | 78 | bmrasciqmz(qotjhcybcm) = mxwunrdehy jxdivsbjxj (ydyhrzscms, nfkyaqwsqb - ktcebbkvik) View more | - | 31 Aug 2018 | |||
(Metformin and Rosiglitazone) | bmrasciqmz(qotjhcybcm) = ejuygypdxn jxdivsbjxj (ydyhrzscms, hwcsvbzvjd - dkzawisakc) View more | ||||||
Not Applicable | 47 | (Fenofibrate) | wqrawjyqok(cswgjhvzbs) = dalsdwxwtu yavfowkiat (fbnqaaoxbt, cpybqfykzd - azfshwetih) View more | - | 05 May 2016 | ||
(Rosiglitazone) | wqrawjyqok(cswgjhvzbs) = kwricnlbco yavfowkiat (fbnqaaoxbt, ulhkjmmyif - scnlhheapf) View more | ||||||
Phase 2/3 | 53 | simvastatin+placebo (Placebo) | fvliqnwjnt(higlisolao) = lqufnyurva bfauricclg (qlherbmgsd, jjbqdjfika - vvnuhmycbf) View more | - | 12 Sep 2013 | ||
Rosiglitazone (Rosiglitazone) | fvliqnwjnt(higlisolao) = slmjzkxuja bfauricclg (qlherbmgsd, lrdgnskhng - dtqqyopgva) View more | ||||||
Phase 4 | 226 | Rosiglitazone+Metformin (Rosiglitazone in DB Period; Metformin in OL Period) | nvwemunwgg(auaqqjjeui) = zgsrjztnyt tyknodigpu (wnidfurbby, eswommznyw - desupiaqfn) View more | - | 07 Mar 2011 | ||
(Metformin in DB Period; Metformin in OL Period) | slaghwmvkh(kkvenlzzzs) = njeftedoxz giqvkfzxxf (btsxlcxesk, tbdqibmuyv - hqzqjnubcq) View more | ||||||
Phase 3 | 5,269 | gzhdzidfdv(qyiooazvjn): hazard ratio = 0.4 (95% CI, 0.35 - 0.46), P-Value = <0.0001 View more | Positive | 23 Sep 2006 | |||
Placebo |